by Madaline Spencer | Mar 10, 2023
Art Levin, PhD, distinguished scientist and strategic leader and member of the company’s board of directors at Avidity Biosciences, at Avidity Biosciences, gives an overview of myotonic dystrophy type 1 (DM1). As explained by Dr. Levin, myotonic dystrophy type...
by Madaline Spencer | Mar 9, 2023
Kyle Wood, MD, Associate Professor of Urology, University of Alabama at Birmingham, discusses the results of the phase 1b study evaluating SYNB8802 for the treatment of enteric hyperoxaluria. Enteric hyperoxaluria is a rare metabolic disorder characterized by...
by Madaline Spencer | Mar 1, 2023
Catherine Nester, BSN, Vice President of Physician and Patient Strategies at Inozyme Pharma, explains the prevalence of Ectonucleotide pyrophosphatase/phosphodiesterase 1Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Deficiency. ENPP1 Deficiency...
